Search results for " innovation"

Article Drugs, At What Cost?
Generics, market dynamics, and global demand are changing drug spending patterns. The underlying question for any drug in development is: What price can (or will) patients pay for the needed…

Article Climate Change in Outsourcing
As 2013 draws to a close, the bio/pharmaceutical industry continues to be reshaped by changes in the business climate. Financial, political, and scientific developments that began 10 years ago conti…

Article Navigating Emerging Markets: Middle East and North Africa
The pharmaceutical industry grows despite conflict in the Middle East. The Middle East and North Africa have been rocked in recent years by upheaval ranging from moderate protest to full…

Article Biosimilars Development and Supply: How Complex Can the Process Be?
As the complex requirements of manufacturing biologics are manifold, it is important that biomanufacturing companies adopt quality-by-design principles. Countries around the world face a gro…

Article Prescribing Caution for Biosimilars
In statehouses around the country, lawmakers are beginning to address the complexities of cutting-edge biotech drugs and the regulatory issues related to the interchangeability of biosimilar medicin…

Article Essentials in Quality Risk Management
Quality risk management is an essential element of every aspect of drug development and manufacturing throughout the product lifecycle. Quality risk management (QRM), as defined in Internatio…

Article Flexibility in Biopharmaceutical Manufacturing
Maintaining flexibility in biopharmaceutical manufacturing can deliver positive results. By: Simon Chalk BioPharm International There is a high degree of consensus in the biomanuf…

Article Milestones and Moderate Progress in 2012 Drug Approvals
Several of the newly approved products are particularly noteworthy in terms of technological or medical innovation, and it is those products that are discussed in most detail below. As Adcetris and Ey…

Previous Page